A New Medicine In The Fight To Manage Parkinson’s
What Is Ongentys? Also known by its generic name, opicapone, Ongentys is a new COMT inhibitor that was approved by the FDA in April 2020 for use in the treatment of off episodes for patients with Parkinson’s disease. Currently, COMT inhibitors that are on the market consist of tolcapone and entacapone, and while both products […]